START FREE TRIAL
Home Materials DuPont de Nemours, Inc.

DuPont de Nemours, Inc.

$19.00

SKU: DD-1 Category:

Description

DuPont’s $469 Million EBITDA Milestone — Can Its Margin Expansion Continue?

 

DuPont de Nemours, Inc. reported its third quarter 2026 financial results with several indicators showing continued operational strength alongside some areas of cautious outlook. The company delivered net sales of $1.9 billion, reflecting a 4% increase from the prior year driven by 5% organic growth partially offset by a 1% currency headwind. Both segments—Healthcare & Water Technologies and Diversified Industrials—contributed to growth, with Healthcare & Water Technologies up 4% organically, and Diversified Industrials up 5% organically. Operating EBITDA rose 8% to $469 million, resulting in a margin expansion of 90 basis points to 25.1%. Adjusted EPS increased by 31% to $2.09, supported by operational improvements, capital allocation, and tax benefits. The company highlighted productivity initiatives as a considerable contributor to margin expansion, with net productivity improvements exceeding 2% in the quarter, particularly in cost of goods sold and procurement efforts amidst a challenging input cost environment.